Rebecca Smith

Rebecca Smith

Auto-generated profile, based on publicly available information

Rebecca Smith

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
HSHafida Sellou
Hafida Sellou
TLThéo Lebeaupin
Théo Lebeaupin
CCCatherine Chapuis
Catherine Chapuis
RSRebecca Smith
Rebecca Smith
AHAnna Hegele
Anna Hegele
SHSébastien Huet
Sébastien Huet
Chromatin relaxation is one of the earliest cellular responses to DNA damage. However, what determines these structural changes, including their ATP requirement, is not well understood. Using live-cell imaging and laser microirradiation to induce DNA lesions, we show that the local chromatin relaxation at DNA damage sites is regulated by PARP1 enzymatic activity. We also report that H1 is mobilized at DNA damage sites, but, since this mobilization is largely independent of poly(ADP-ribosyl)ation, it cannot solely explain the chromatin relaxation. Finally, we demonstrate the involvement of Alc1, a poly(ADP-ribose)- and ATP-dependent remodeler, in the chromatin-relaxation process. Deletion of Alc1 impairs chromatin relaxation after DNA damage, while its overexpression strongly enhances relaxation. Altogether our results identify Alc1 as an important player in the fast kinetics of the NAD+- and ATP-dependent chromatin relaxation upon DNA damage in vivo.

18 December 2020 in Science Advances
Verified
Journal Article
Open access
SJSzilvia Juhász
Szilvia Juhász
RSRebecca Smith
Rebecca Smith
TSTamás Schauer
Tamás Schauer
DSDóra Spekhardt
Dóra Spekhardt
HMHasan Mamar
Hasan Mamar
GTGyula Timinszky
Gyula Timinszky
ALC1 mobilizes trapped PARP1, allowing the subsequent recruitment of downstream repair factors to initiate efficient repair.

1 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPEvgeniia Prokhorova
Evgeniia Prokhorova
FZFlorian Zobel
Florian Zobel
RSRebecca Smith
Rebecca Smith
SZSiham Zentout
Siham Zentout
IGIan Gibbs-Seymour
Ian Gibbs-Seymour
IAIvan Ahel
Ivan Ahel
Poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 are recruited and activated by DNA damage, resulting in ADP-ribosylation at numerous sites, both within PARP1 itself and in other proteins. Several PARP1 and PARP2 inhibitors are currently employed in the clinic or undergoing trials for treatment of various cancers. These drugs act primarily by trapping PARP1 on damaged chromatin, which can lead to cell death, especially in cells with DNA repair defects. Although PARP1 trapping is thought to be caused primarily by the catalytic inhibition of PARP-dependent modification, implying that ADP-ribosylation (ADPr) can counteract trapping, it is not known which exact sites are important for this process. Following recent findings that PARP1- or PARP2-mediated modification is predominantly serine-linked, we demonstrate here that serine ADPr plays a vital role in cellular responses to PARP1/PARP2 inhibitors. Specifically, we identify three serine residues within PARP1 (499, 507, and 519) as key sites whose efficient HPF1-dependent modification counters PARP1 trapping and contributes to inhibitor tolerance. Our data implicate genes that encode serine-specific ADPr regulators, HPF1 and ARH3, as potential PARP1/PARP2 inhibitor therapy biomarkers.

4 May 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RSRebecca Smith
Rebecca Smith
HSHafida Sellou
Hafida Sellou
CCCatherine Chapuis
Catherine Chapuis
SHSébastien Huet
Sébastien Huet
GTGyula Timinszky
Gyula Timinszky
One of the first events to occur upon DNA damage is the local opening of the compact chromatin architecture, facilitating access of repair proteins to DNA lesions. This early relaxation is triggered by poly(ADP-ribosyl)ation by PARP1 in addition to ATP-dependent chromatin remodeling. CHD4 recruits to DNA breaks in a PAR-dependent manner, although it lacks any recognizable PAR-binding domain, and has the ability to relax chromatin structure. However, its role in chromatin relaxation at the site of DNA damage has not been explored. Using a live cell fluorescence three-hybrid assay, we demonstrate that the recruitment of CHD4 to DNA damage, while being poly(ADP-ribosyl)ation-dependent, is not through binding poly(ADP-ribose). Additionally, we show that CHD3 is recruited to DNA breaks in the same manner as CHD4 and that both CHD3 and CHD4 play active roles in chromatin remodeling at DNA breaks. Together, our findings reveal a two-step mechanism for DNA damage induced chromatin relaxation in which PARP1 and the PAR-binding remodeler activities of Alc1/CHD1L induce an initial chromatin relaxation phase that promotes the subsequent recruitment of CHD3 and CHD4 via binding to DNA for further chromatin remodeling at DNA breaks.

15 September 2023 in Science Advances
Verified
Journal Article
Open access
NĐNina Đukić
Nina Đukić
ØSØyvind Strømland
Øyvind Strømland
JEJonas Damgaard Elsborg
Jonas Damgaard Elsborg
DMDeeksha Munnur
Deeksha Munnur
KZKang Zhu
Kang Zhu
IAIvan Ahel
Ivan Ahel
PARP14 is a mono–ADP-ribosyl transferase involved in the control of immunity, transcription, and DNA replication stress management. However, little is known about the ADP-ribosylation activity of PARP14, including its substrate specificity or how PARP14-dependent ADP-ribosylation is reversed. We show that PARP14 is a dual-function enzyme with both ADP-ribosyl transferase and hydrolase activity acting on both protein and nucleic acid substrates. In particular, we show that the PARP14 macrodomain 1 is an active ADP-ribosyl hydrolase. We also demonstrate hydrolytic activity for the first macrodomain of PARP9. We reveal that expression of a PARP14 mutant with the inactivated macrodomain 1 results in a marked increase in mono(ADP-ribosyl)ation of proteins in human cells, including PARP14 itself and antiviral PARP13, and displays specific cellular phenotypes. Moreover, we demonstrate that the closely related hydrolytically active macrodomain of SARS2 Nsp3, Mac1, efficiently reverses PARP14 ADP-ribosylation in vitro and in cells, supporting the evolution of viral macrodomains to counteract PARP14-mediated antiviral response.

3 September 2018 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
MKMarek Kozlowski
Marek Kozlowski
DCDavid Corujo
David Corujo
MHMichael Hothorn
Michael Hothorn
IGIva Guberovic
Iva Guberovic
IMImke K Mandemaker
Imke K Mandemaker
ALAndreas G Ladurner
Andreas G Ladurner